Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
INSULIN GLARGINE
Lantus
Diabetes Mellitus, Type 2
LANTU_L_04980AFICIONADONCT01127269Summary
INSULIN GLARGINE
Lantus
Diabetes Mellitus, Type 2
LANTU_L_05146SeLanNCT01234597Summary
INSULIN GLARGINE
Lantus
Diabetes Mellitus, Type 2
LANTU_L_05191PEN PREFERENCENCT01226043Tabulated Results
INSULIN GLARGINE
Lantus Solostar
Diabetes Mellitus, Type 2
LANTU_L_05477GAUDINCT01461577Summary
INSULIN GLARGINE
Lantus
Diabetes Mellitus, Type 2
LANTU_R_04889ATLASNCT01169818Summary
INSULIN GLARGINE
Lantus
Diabetes Mellitus, Type 1
LANTU_R_05033SUBSTITUTENCT01204593Summary
INSULIN GLARGINE
Lantus
Diabetes Mellitus, Type 2
LANTU_R_05048CHANGINGNCT01203111Summary
INSULIN GLARGINE
Lantus
Diabetes Mellitus, Type 2
LANTUL06638TEDNCT02027753Summary
INSULIN GLARGINE
Lantus
Diabetes Mellitus, Type 2
LANTUL07190BEYOND III/ FPG GOALNCT02545842Summary
INSULIN GLARGINE
Lantus
Diabetes Mellitus, Type 2
LANTUL07191Glargine Starting doseNCT02836704Summary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted